发明名称 |
Generation of Patient-Specific Differentiated Cell Types by Epigenetic Induction |
摘要 |
Disclosure of a mammalian cytoplasmic donor cell line. Disclosure of a patient specific cell line. Methods to obtain a mammalian cytoplasmic donor cell line by fusing a differentiated mammalian cell and a functionally enucleated mammalian embryonic cell line. Methods to obtain a mammalian cytoplasmic donor cell line by fusing a differentiated mammalian cell and a functionally enucleated human cancer cell. Methods to obtain a patient specific cell line of a cell type similar to a mammalian cytoplasmic donor cell line by functionally enucleating the mammalian cytoplasmic donor cell line and fusing the functionally enucleated mammalian cytoplasmic donor cell line with a differentiated cell obtained from the patient. A method of treatment of a human patient by administering the patient-specific cell line to the patient. |
申请公布号 |
US2016289636(A1) |
申请公布日期 |
2016.10.06 |
申请号 |
US201615186379 |
申请日期 |
2016.06.17 |
申请人 |
Gopal Thiru Venkat |
发明人 |
Gopal Thiru Venkat |
分类号 |
C12N5/0793 |
主分类号 |
C12N5/0793 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of preparing a self-propagating dopaminergic neuron cell specific to a human patient, the method comprising:
(a) obtaining a human cancer cell; (b) treating the human cancer cell with a DNA interchelating agent to obtain a DNA interchelating agent treated human cancer cell, (c) treating the DNA interchelating agent treated human cancer cell with an agglutinin to obtain an agglutinin-treated human cancer cell; (d) fusing the agglutinin-treated human cancer cell from step (c) with a human dopaminergic neuron cell to obtain a self-propagating human dopaminergic neuron cytoplasmic donor cell; (e) treating the self-propagating human dopaminergic neuron cytoplasmic donor cell from step (d) with a DNA interchelating agent to obtain a DNA interchelating agent treated human dopaminergic neuron cytoplasmic donor cell; (f) treating the DNA interchelating agent treated human dopaminergic neuron cytoplasmic donor cell from step (e) with an agglutinin to obtain an agglutinin-treated human dopaminergic neuron cytoplasmic donor cell; (g) fusing the agglutinin-treated human dopaminergic neuron cytoplasmic donor cell from step (f) with a histone deacetylase inhibitor treated somatic cell from a human patient whereby a self-propagating dopaminergic neuron cell specific to the human patient is obtained. |
地址 |
North Potomac MD US |